Recent developments in 5lipoxygenase inhibitors

Author： Julémont Fabien   Dogné Jean-Michel   Laeckmann Didier   Pirotte Bernard   Leval Xavier de  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.1, 2003-01, pp. : 1-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-Lipoxygenase inhibitors: a review of recent developments and patents

By Pergola Carlo   Werz Oliver  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 3, 2010-03 ,pp. : 355-375

Informa Healthcare

Access to resources Recommend Favorite

Recent developments in C5/C5a inhibitors

By Proctor Lavinia M   Woodruff Trent M   Taylor Stephen M  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 445-458

Informa Healthcare

Access to resources Recommend Favorite

5-Lipoxygenase inhibitors: a review of recent patents (2010 - 2012)

By Hofmann Bettina   Steinhilber Dieter  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 895-909

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of cyclooxygenase-2 and 5-lipoxygenase

By  

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 9, 1997-09 ,pp. : 1041-1042

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 15, Iss. 27, 2009-09 ,pp. : 3116-3132

Bentham Science Publishers

Access to resources Recommend Favorite